Combined Use of PDE5 Inhibitors and Nitrates in the Treatment of Pulmonary Arterial Hypertension in Patients With Heart Failure

Journal of Cardiac Failure

Volumn 15, Issue 1, 2009, Pages 31-34

  Stehlik, Josef ^a,b   Movsesian, Matthew A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

cyclic GMP; Pulmonary vasodilation

Indexed keywords

GLYCERYL TRINITRATE; HYDRALAZINE; ISOSORBIDE DINITRATE; MILRINONE; SILDENAFIL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIAC PATIENT; CARDIOMYOPATHY; CASE REPORT; DIZZINESS; DRUG DOSE INCREASE; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEART ARREST; HEART ATRIUM PRESSURE; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYNCOPE; SYSTEMIC VASCULAR RESISTANCE; TREATMENT DURATION; VASODILATATION;

CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DRUG THERAPY, COMBINATION; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; NITRO COMPOUNDS; NITROGLYCERIN; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PULMONARY ARTERY; PURINES; SULFONES; VASODILATION; VASODILATOR AGENTS;

EID: 58849136328     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.09.005     Document Type: Article

References (18)

1. Lincoln T.M., Dey N., and Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91 (2001) 1421-1430
2. Ghofrani H.A., Voswinckel R., Reichenberger F., Olschewski H., Haredza P., Karadaş B., et al. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol 44 (2004) 1488-1496
3. Alaeddini J., Uber P.A., Park M.H., Scott R.L., Ventura H.O., and Mehra M.R. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol 94 (2004) 1475-1477
4. Trachte A.L., Lobato E.B., Urdaneta F., Hess P.J., Klodell C.T., Martin T.D., et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 79 (2005) 194-197
5. Michelakis E., Tymchak W., Lien D., Webster L., Hashimoto K., and Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105 (2002) 2398-2403
6. Michelakis E.D., Tymchak W., Noga M., Webster L., Wu X.C., Lien D., et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 108 (2003) 2066-2069
7. Galiè N., Ghofrani H.A., Torbicki A., Barst R.J., Rubin L.J., Badesch D., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
8. Behling A., Rohde L.E., Colombo F.C., Goldraich L.A., Stein R., and Clausell N. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. J Card Fail 14 (2008) 189-197
9. Lewis G.D., Lachmann J., Camuso J., Lepore J.J., Shin J., Martinovic M.E., et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115 (2007) 59-66
10. Lewis G.D., Shah R., Shahzad K., Camuso J.M., Pappagianopoulos P.P., Hung J., et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 116 (2007) 1555-1562
11. Guazzi M., Samaja M., Arena R., Vicenzi M., and Guazzi M.D. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 50 (2007) 2136-2144
12. Lepore J.J., Maroo A., Bigatello L.M., Dec G.W., Zapol W.M., Bloch K.D., et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 127 (2005) 1647-1653
13. Parker J.D., Bart B.A., Webb D.J., Koren M.J., Siegel R.L., Wang H., et al. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial. Crit Care Med 35 (2007) 1863-1868
14. Abramson S.V., Burke J.F., Kelly Jr. J.J., Kitchen III J.G., Dougherty M.J., Yih D.F., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 116 (1992) 888-895
15. Ghio S., Gavazzi A., Campana C., Inserra C., Klersy C., Sebastiani R., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37 (2001) 183-188
16. Butler J., Stankewicz M.A., Wu J., Chomsky D.B., Howser R.L., Khadim G., et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant 24 (2005) 170-177
17. Cheitlin M.D., Hutter Jr. A.M., Brindis R.G., Ganz P., Kaul S., Russell Jr. R.O., et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 33 (1999) 273-282
18. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) e1-e157